ADIL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 14.47%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Adial Pharmaceuticals Insider Trading History Chart

Adial Pharmaceuticals Share Price & Price History

^$1.02

▼ -0.0015 (-0.15%)

As of 10/30/2024 01:01 PM ET

Days: 30 | 90 | 365

The real reason Elon is fully endorsing Trump

From Porter & Company | Ad

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

Adial Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/29/2023	Kevin Schuyler	Director	Buy	700	$2.74	$1,918.00	700
11/29/2021	William B. Stilley, III	CEO	Buy	400	$64.75	$25,900.00
11/26/2021	James W. Newman, Jr.	Director	Buy	400	$71.25	$28,500.00

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

SEC Filings (Institutional Ownership Changes) for Adial Pharmaceuticals (NASDAQ:ADIL)

16.41% of Adial Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adial Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/9/2024	Renaissance Technologies LLC	34,346	$39K	0.0%	-32.8%	0.811%
5/20/2024	Virtu Financial LLC	20,469	$27K	0.0%	N/A	0.484%
2/13/2024	Armistice Capital LLC	159,000	$0.30M	0.0%	N/A	9.578%
11/9/2023	Manchester Capital Management LLC	48,097	$0.13M	0.0%	-96.0%	3.942%
5/9/2023	Manchester Capital Management LLC	1,202,452	$0.42M	0.1%	N/A	4.216%
11/7/2022	Virtu Financial LLC	77,694	$27K	0.0%	+142.7%	0.301%
8/2/2022	Thompson Davis & CO. Inc.	21,000	$28K	0.0%	N/A	0.088%
7/22/2022	Truist Financial Corp	33,862	$45K	0.0%	N/A	0.142%
7/13/2022	Private Advisor Group LLC	21,400	$29K	0.0%	-37.3%	0.090%
11/12/2021	Oppenheimer & Co. Inc.	38,500	$0.17M	0.0%	+37.5%	0.190%
11/12/2021	NorthRock Partners LLC	10,000	$43K	0.0%	N/A	0.049%
10/29/2021	Commonwealth Equity Services LLC	36,461	$0.16M	0.0%	+25.5%	0.180%
9/17/2021	Virtu Financial LLC	31,038	$79K	0.0%	N/A	0.153%
8/16/2021	State Street Corp	48,954	$0.13M	0.0%	N/A	0.260%
8/13/2021	Northern Trust Corp	21,873	$56K	0.0%	N/A	0.116%
8/13/2021	Geode Capital Management LLC	88,246	$0.23M	0.0%	+13.2%	0.469%
8/13/2021	Vanguard Group Inc.	585,035	$1.49M	0.0%	+172.4%	3.112%
8/11/2021	Commonwealth Equity Services LLC	29,050	$74K	0.0%	+31.7%	0.155%
8/3/2021	Oppenheimer & Co. Inc.	28,000	$71K	0.0%	+93.1%	0.152%
7/17/2021	Golden Green Inc.	24,700	$63K	0.0%	N/A	0.134%
5/14/2021	Dimensional Fund Advisors LP	31,410	$76K	0.0%	+68.8%	0.179%
5/13/2021	Barclays PLC	15,850	$38K	0.0%	N/A	0.091%
5/12/2021	Rede Wealth LLC	15,000	$36K	0.0%	N/A	0.086%
5/10/2021	Oppenheimer & Co. Inc.	14,500	$35K	0.0%	N/A	0.083%
5/4/2021	Commonwealth Equity Services LLC	22,050	$53K	0.0%	+107.3%	0.126%
4/22/2021	Private Advisor Group LLC	36,650	$89K	0.0%	N/A	0.212%
3/8/2021	Dimensional Fund Advisors LP	18,612	$32K	0.0%	N/A	0.129%
2/25/2021	Dimensional Fund Advisors LP	18,612	$32K	0.0%	N/A	0.129%
2/10/2021	Renaissance Technologies LLC	98,900	$0.17M	0.0%	+6.5%	0.687%
12/11/2020	Virtu Financial LLC	18,902	$42K	0.0%	N/A	0.131%

Data available starting January 2016

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Today's Range

Now: $1.02

$1.01

$1.02

50 Day Range

MA: $1.02

$0.94

$1.17

52 Week Range

Now: $1.02

$0.77

$4.17

Volume

23,664 shs

Average Volume

2,815,122 shs

Market Capitalization

$6.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.3

Who are the company insiders with the largest holdings of Adial Pharmaceuticals?: Adial Pharmaceuticals' top insider shareholders include:
Kevin Schuyler (Director)
Learn More about top insider investors at Adial Pharmaceuticals.